4 drug(s) with this reaction
10,965 total reports
Abdominal Discomfort has been reported as an adverse reaction across 4 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 10,965 adverse event reports mention abdominal discomfort in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with abdominal discomfort, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have abdominal discomfort listed in their FDA adverse event reports, sorted by report count:
In addition to abdominal discomfort, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
4 drug(s) manufactured by Amgen Inc have abdominal discomfort listed in their FDA adverse event reports: APREMILAST, DENOSUMAB, ERENUMAB-AOOE, CINACALCET HYDROCHLORIDE.
There are a combined 10,965 reports of abdominal discomfort across 4 Amgen Inc drug(s) in the FDA adverse event database.